CX-1837

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCX-1837
Drug Alias NameCX-1837
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsAutistic Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Mental Health (Nimh)
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Mental Health (Nimh)
Inactive CompaniesN/A
Active IndicationsAutistic Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A